This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Lincoln National Q4 Earnings Beat on Strong Group Protection Unit
by Zacks Equity Research
LNC's Q4 results benefit from strong insurance premiums in the Annuities unit and new business growth in the Group Protection segment, partly offset by escalating benefits expense.
MetLife Q4 Earnings Miss Estimates on Weak RIS & EMEA Unit
by Zacks Equity Research
Management expects a variable investment income of $1.7 billion for 2025.
Allstate Q4 Earnings Beat on Strong Premium & Investment Income
by Zacks Equity Research
ALL agrees to divest the Group health business to Nationwide for $1.25 billion in cash.
Here's Why Marsh & McLennan (MMC) is a Strong Growth Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
AON Q4 Earnings Surpass Estimates on New Business Growth
by Zacks Equity Research
Aon's Q4 results reflect strong organic growth and NFP acquisition synergies. However, rising costs weigh on margins.
Marsh & McLennan Q4 Earnings Beat Estimates on Solid US Business
by Zacks Equity Research
MMC's fourth-quarter revenues benefit from strong performance in the Marsh unit and Consulting segment.
Marsh & McLennan (MMC) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Marsh & McLennan (MMC) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Marsh & McLennan (MMC) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 6.86% and 2.54%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Will High Operating Costs Ail Marsh & McLennan in Q4 Earnings?
by Zacks Equity Research
MMC's Q4 results are likely to be aided by strength in the Risk and Insurance Services and Consulting segments, partly offset by elevated compensation and benefits expenses.
Aon (AON) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Aon (AON) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Marsh & McLennan (MMC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Marsh & McLennan (MMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Buy, Sell or Hold Marsh & McLennan Stock at a 7.47X P/B?
by Zacks Equity Research
MMC is currently aided by strong segmental contribution, margin expansion and inorganic growth initiatives.
MMC's Unit Enhances Offerings With Acumen Solutions Acquisition
by Zacks Equity Research
Marsh & McLennan's unit acquires Acumen Solutions, enhances offering for clients and deepens expertise in key sectors.
Zacks Industry Outlook Brown and Brown, Marsh & McLennan, Arthur J. Gallagher & Co and Willis Towers Watson
by Zacks Equity Research
Brown and Brown, Marsh & McLennan, Arthur J. Gallagher & Co and Willis Towers Watson have been highlighted in this Industry Outlook article.
4 Stocks to Watch From the Prospering Insurance Brokerage Industry
by Sushmita Sarker
Higher demand for insurance products, strategic acquisitions and the adoption of technology should drive the performance of Zacks Insurance Brokerage industry players like BRO, MMC, AJG and WTW.
AIG Stock Rises 12.1% YTD: Should Investors Hold or Fold?
by Zacks Equity Research
AIG's improving business mix, growing returns on investments and ongoing expense discipline position it well for long-term growth.
Here's Why Investors Should Hold Marsh & McLennan Stock for Now
by Zacks Equity Research
MMC is currently aided by strong segmental contribution, solid retention rates and tactical deployment of capital.
Top Analyst Reports for Broadcom, Merck & Qualcomm
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Merck & Co. (MRK) and Qualcomm (QCOM), as well as a micro-cap stock, Natural Health Trends Corp. (NHTC).
Primerica Q3 Earnings Beat on Strong Term Life Insurance Sales
by Zacks Equity Research
PRI's third-quarter earnings benefit from higher premiums and Term Life insurance sales. Higher expenses partially offset the positives.
eHealth Incurs Q3 Loss on Lower Commissions, Shares Down 6.1%
by Zacks Equity Research
EHTH's third-quarter results suffer from lower commissions and other revenues. Lower expenses partially offset the negatives.
Marsh & McLennan Expands Middle-Market Reach With McGriff Integration
by Zacks Equity Research
The move will likely expand MMC's client base, service offerings and cross-selling opportunities, triggering revenue growth.
Regional Management Shares Plunge 9.3% Despite Q3 Earnings Beat
by Zacks Equity Research
RM's third-quarter earnings benefit from rising interest and fee income and improved efficiency ratio. The hurricane impact, coupled with declining net insurance income, partially offset the results.
Encore Capital Q3 Earnings Miss Estimates on Lower Purchases by Cabot
by Zacks Equity Research
ECPG's third-quarter earnings suffer from rising operating expenses and the competitive environment in the U.K. Improved portfolio purchasing in the United States partially offset the negatives.
ProAssurance Q3 Earnings Beat on Strong Net Investment Income
by Zacks Equity Research
PRA's third-quarter earnings benefit from improving underwriting results in its Specialty P&C segment. Declining profits in the Segregated Portfolio Cell Reinsurance unit partially offset the positives.
PRA Group's Shares Up 17.8% Since Q3 Earnings Beat Estimates
by Zacks Equity Research
PRAA's third-quarter results benefit from strong cash collection and portfolio income growth. Higher expenses partially offset the positives.